Diagnosing nontuberculous mycobacterial lung disease. A process in evolution.
Assessing the impact of the diagnosis if NTM lung disease on the patient and choosing appropriate therapy are separate considerations. Health care professionals have progressed from an era when patients had unrecognized, progressive, and untreated NTM disease to an era when NTM disease is diagnosed frequently but therapy is either unnecessary or possibly worse than the disease. Perhaps the 1990 ATS statement was correct. The problem is not diagnosing patients with NTM lung disease, the problem is deciding what to do with them after they are diagnosed.
Griffith
David E
DE
Clinical Tuberculosis Services, University of Texas Health Center, Tyler, Texas, USA. david.griffith@uthct.edu
Brown-Elliott
Barbara A
BA
Wallace
Richard J
RJ
D006801:Humans; D009164:Mycobacterium Infections / Q000175:diagnosis*; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis*